{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T03:20:58Z","timestamp":1787628058373,"version":"build-2736575974"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research Bulletin"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.brainresbull.2023.04.003","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T11:28:48Z","timestamp":1681730928000},"page":"3-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Antidepressant effect of 4-Butyl-alpha-agarofuran via HPA axis and serotonin system"],"prefix":"10.1016","volume":"198","author":[{"given":"Hongyue","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nianying","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinnan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longgang","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dali","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.brainresbull.2023.04.003_bib1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0003-3472(73)80065-X","article-title":"Tests for emotionality in rats and mice: a review","volume":"21","author":"Archer","year":"1973","journal-title":"Anim. Behav."},{"issue":"1","key":"10.1016\/j.brainresbull.2023.04.003_bib2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.pharmthera.2012.09.006","article-title":"Serotonin receptors involved in antidepressant effects","volume":"137","author":"Artigas","year":"2013","journal-title":"Pharm. Ther."},{"issue":"5","key":"10.1016\/j.brainresbull.2023.04.003_bib3","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.euroneuro.2013.04.013","article-title":"Developments in the field of antidepressants, where do we go now","volume":"25","author":"Artigas","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.brainresbull.2023.04.003_bib4","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1146\/annurev.pharmtox.44.101802.121410","article-title":"CRF and CRF receptors: role in stress responsivity and other behaviors","volume":"44","author":"Bale","year":"2004","journal-title":"Annu Rev. Pharm. Toxicol."},{"issue":"9","key":"10.1016\/j.brainresbull.2023.04.003_bib5","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s40263-013-0071-0","article-title":"Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research","volume":"27","author":"Celada","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.brainresbull.2023.04.003_bib6","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1476-5381.1963.tb01302.x","article-title":"A method for assessing the effects of drugs on the central actions of 5-hydroxytryptamine","volume":"20","author":"Corne","year":"1963","journal-title":"Br. J. Pharm. Chemother."},{"issue":"9","key":"10.1016\/j.brainresbull.2023.04.003_bib7","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.tips.2008.05.004","article-title":"Serotonin and depression: pathophysiological mechanism or marketing myth","volume":"29","author":"Cowen","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.brainresbull.2023.04.003_bib8","unstructured":"Delgado, P.L. (2000). Depression: the case for a monoamine deficiency. The Journal of Clinical Psychiatry 61 Suppl 6."},{"issue":"8","key":"10.1016\/j.brainresbull.2023.04.003_bib9","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1176\/appi.ajp.2020.19080848","article-title":"Hormonal Treatments for Major Depressive Disorder: State of the Art","volume":"177","author":"Dwyer","year":"2020","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.brainresbull.2023.04.003_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109329","article-title":"Anti-depressant effect of cerebrolysin in reserpine-induced depression in rats: Behavioral, biochemical, molecular and immunohistochemical evidence","volume":"334","author":"El-Marasy","year":"2021","journal-title":"Chem. Biol. Inter."},{"issue":"2","key":"10.1016\/j.brainresbull.2023.04.003_bib11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S2215-0366(21)00395-3","article-title":"Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"9","year":"2022","journal-title":"Lancet Psychiatry."},{"issue":"3","key":"10.1016\/j.brainresbull.2023.04.003_bib12","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s12264-014-1508-2","article-title":"Hypothalamic-pituitary-adrenal axis function during perinatal depression","volume":"31","author":"Gelman","year":"2015","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.brainresbull.2023.04.003_bib13","unstructured":"Guo, J., Wang, W., Fang, H., Yin, D., Sun, S., Liu, R., Li, C., Liu, H., Wang, D., Liu, Q., et al., 2000, Novel agarofuran derivatives, their preparation, pharmaceutical composition containing them and their use as medicine, in: E.P. Office (Ed.)."},{"issue":"10","key":"10.1016\/j.brainresbull.2023.04.003_bib14","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/nrn.2016.94","article-title":"Region-specific roles of the corticotropin-releasing factor-urocortin system in stress","volume":"17","author":"Henckens","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"issue":"11","key":"10.1016\/j.brainresbull.2023.04.003_bib15","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.tips.2003.09.011","article-title":"Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders","volume":"24","author":"Holmes","year":"2003","journal-title":"Trends Pharm. Sci."},{"issue":"2","key":"10.1016\/j.brainresbull.2023.04.003_bib16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1210\/edrv-17-2-187","article-title":"Antidepressants and hypothalamic-pituitary-adrenocortical regulation","volume":"17","author":"Holsboer","year":"1996","journal-title":"Endocr. Rev."},{"issue":"2\u20133","key":"10.1016\/j.brainresbull.2023.04.003_bib17","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ejphar.2007.12.032","article-title":"Central CRH system in depression and anxiety--evidence from clinical studies with CRH1 receptor antagonists","volume":"583","author":"Holsboer","year":"2008","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.brainresbull.2023.04.003_bib18","first-page":"61","article-title":"Stress hormone regulation: biological role and translation into therapy","author":"Holsboer","year":"2010","journal-title":"Annu Rev. Psychol."},{"issue":"11","key":"10.1016\/j.brainresbull.2023.04.003_bib19","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.biopsych.2007.05.003","article-title":"Glucocorticoid receptor antagonists hasten and augment neurochemical responses to a selective serotonin reuptake inhibitor antidepressant","volume":"62","author":"Johnson","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.brainresbull.2023.04.003_bib20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.psyneuen.2015.12.019","article-title":"Chronic mild stress influences nerve growth factor through a matrix metalloproteinase-dependent mechanism","volume":"66","author":"Kucharczyk","year":"2016","journal-title":"Psychoneuroendocrinology"},{"issue":"18","key":"10.1016\/j.brainresbull.2023.04.003_bib21","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1007\/s00018-009-0055-x","article-title":"Depression and antidepressants: molecular and cellular aspects","volume":"66","author":"Lanni","year":"2009","journal-title":"Cell. Mol. Life Sci.: CMLS"},{"issue":"2","key":"10.1016\/j.brainresbull.2023.04.003_bib22","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF00435311","article-title":"Adrenergic nonspecific potentiation of yohimbine toxicity in mice by antidepressants and related drugs and antiyohimbine action of antiadrenergic and serotonergic drugs","volume":"70","author":"Lapin","year":"1980","journal-title":"Psychopharmacol. (Berl. )"},{"issue":"3","key":"10.1016\/j.brainresbull.2023.04.003_bib23","first-page":"125","article-title":"Synthesis and CNS activities of alpha-agarofuran","volume":"13","author":"Liu","year":"2003","journal-title":"derivatives"},{"issue":"5","key":"10.1016\/j.brainresbull.2023.04.003_bib24","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nn.2529","article-title":"CRF receptor 1 regulates anxiety behavior via sensitization of 5-HT2 receptor signaling","volume":"13","author":"Magalhaes","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.brainresbull.2023.04.003_bib25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.neubiorev.2013.11.009","article-title":"Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects","volume":"38","author":"Mahar","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.brainresbull.2023.04.003_bib26","first-page":"1","article-title":"Developmental minocycline treatment reverses the effects of neonatal immune activation on anxiety-and depression-like behaviors, hippocampal inflammation","volume":"120","author":"Majidi","year":"2016","journal-title":"HPA axis Act. adult mice"},{"issue":"2","key":"10.1016\/j.brainresbull.2023.04.003_bib27","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S2215-0366(15)00436-8","article-title":"Antidepressant augmentation with metyrapone for treatment-resistant depression (the ADD study): a double-blind, randomised, placebo-controlled trial","volume":"3","author":"McAllister-Williams","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"6","key":"10.1016\/j.brainresbull.2023.04.003_bib28","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1523\/JNEUROSCI.4734-03.2004","article-title":"Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain region. The Journal of Neuroscience: the Official","volume":"24","author":"Merali","year":"2004","journal-title":"J. Soc. Neurosci."},{"key":"10.1016\/j.brainresbull.2023.04.003_bib29","article-title":"Persistent adverse effects of antidepressants","volume":"29","author":"Moncrieff","year":"2019","journal-title":"Epidemiol. Psychiatr. Sci."},{"issue":"3","key":"10.1016\/j.brainresbull.2023.04.003_bib30","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0924-977X(96)00015-6","article-title":"5HT2C receptor agonists exhibit antidepressant-like properties in the anhedonia model of depression in rats","volume":"6","author":"Moreau","year":"1996","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.brainresbull.2023.04.003_bib31","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3389\/fncel.2015.00200","article-title":"Suppression of piriform cortex activity in rat by corticotropin-releasing factor 1 and serotonin 2A\/C receptors","volume":"9","author":"Narla","year":"2015","journal-title":"Front. Cell. Neurosci."},{"issue":"4680","key":"10.1016\/j.brainresbull.2023.04.003_bib32","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1126\/science.6334362","article-title":"Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients","volume":"226","author":"Nemeroff","year":"1984","journal-title":"Sci. (N. Y., N. Y. )"},{"issue":"1","key":"10.1016\/j.brainresbull.2023.04.003_bib33","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0896-6273(02)00653-0","article-title":"Neurobiology of depression","volume":"34","author":"Nestler","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.brainresbull.2023.04.003_bib34","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3389\/fphar.2016.00343","article-title":"Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats","volume":"7","author":"Peres","year":"2016","journal-title":"Front Pharm."},{"issue":"2","key":"10.1016\/j.brainresbull.2023.04.003_bib35","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch. Int Pharm. Ther."},{"issue":"1","key":"10.1016\/j.brainresbull.2023.04.003_bib36","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.neuron.2009.12.003","article-title":"5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants","volume":"65","author":"Richardson-Jones","year":"2010","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.brainresbull.2023.04.003_bib37","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0378-8741(01)00393-2","article-title":"Antidepressant effects of the methanol extract of several Hypericum species from the Canary Islands","volume":"79","author":"S\u00e1nchez-Mateo","year":"2002","journal-title":"J. Ethnopharmacol."},{"issue":"6","key":"10.1016\/j.brainresbull.2023.04.003_bib38","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.neubiorev.2004.08.008","article-title":"Serotonin1B receptors: from protein to physiological function and behavior","volume":"28","author":"Sari","year":"2004","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"3","key":"10.1016\/j.brainresbull.2023.04.003_bib39","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0361-9230(87)90109-2","article-title":"Characterization of benzodiazepine withdrawal in high- and low-dose dependent psychiatric inpatients","volume":"19","author":"Schmauss","year":"1987","journal-title":"Brain Res Bull."},{"issue":"1","key":"10.1016\/j.brainresbull.2023.04.003_bib40","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.coph.2011.02.003","article-title":"5-HT and depression: is the glass half-full","volume":"11","author":"Sharp","year":"2011","journal-title":"Curr. Opin. Pharm."},{"issue":"4","key":"10.1016\/j.brainresbull.2023.04.003_bib41","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1073\/pnas.86.4.1398","article-title":"Dopamine turnover and glutathione oxidation: implications for Parkinson disease","volume":"86","author":"Spina","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"3","key":"10.1016\/j.brainresbull.2023.04.003_bib42","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology"},{"issue":"6","key":"10.1016\/j.brainresbull.2023.04.003_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.apsb.2020.02.015","article-title":"TIMP1 preserves the blood-brain barrier through interacting with CD63\/integrin 1 complex and regulating downstream FAK\/RhoA signaling","volume":"10","author":"Tang","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.brainresbull.2023.04.003_bib44","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ynstr.2016.08.002","article-title":"The chronic mild stress (CMS) model of depression: History, evaluation and usage","volume":"6","author":"Willner","year":"2017","journal-title":"Neurobiol. Stress"},{"issue":"2","key":"10.1016\/j.brainresbull.2023.04.003_bib45","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jep.2006.09.042","article-title":"Behavioral, neurochemical and neuroendocrine effects of the ethanolic extract from Curcuma longa L. in the mouse forced swimming test","volume":"110","author":"Xia","year":"2007","journal-title":"J. Ethnopharmacol."},{"issue":"9","key":"10.1016\/j.brainresbull.2023.04.003_bib46","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.psyneuen.2004.02.002","article-title":"HPA axis activation in major depression and response to fluoxetine: a pilot study","volume":"29","author":"Young","year":"2004","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.brainresbull.2023.04.003_bib47","doi-asserted-by":"crossref","unstructured":"Zhang, Q., Feng, J.J., Yang, S., Liu, X.F., Li, J.C., and Zhao, H.J.Brb, 2016, Lateral habenula as a link between thyroid and serotoninergic system modiates depressive symptoms in hypothyroidism rats. 124, 198\u2013205.","DOI":"10.1016\/j.brainresbull.2016.05.007"},{"issue":"1\u20132","key":"10.1016\/j.brainresbull.2023.04.003_bib48","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejphar.2004.09.051","article-title":"Effects of novel anxiolytic 4-butyl-alpha-agarofuran on levels of monoamine neurotransmitters in rats","volume":"504","author":"Zhang","year":"2004","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.brainresbull.2023.04.003_bib49","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/s12888-022-04065-0","article-title":"Alterations of monoamine neurotransmitters, HPA-axis hormones, and inflammation cytokines in reserpine-induced hyperalgesia and depression comorbidity rat model","volume":"22","author":"Zhao","year":"2022","journal-title":"BMC Psychiatry"},{"issue":"7","key":"10.1016\/j.brainresbull.2023.04.003_bib50","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1517\/13543784.13.7.799","article-title":"The therapeutic potential of CRF1 antagonists for anxiety","volume":"13","author":"Zorrilla","year":"2004","journal-title":"Expert Opin. Invest. Drugs"}],"container-title":["Brain Research Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036192302300076X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036192302300076X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T20:53:06Z","timestamp":1759783986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036192302300076X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":50,"alternative-id":["S036192302300076X"],"URL":"https:\/\/doi.org\/10.1016\/j.brainresbull.2023.04.003","relation":{},"ISSN":["0361-9230"],"issn-type":[{"value":"0361-9230","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antidepressant effect of 4-Butyl-alpha-agarofuran via HPA axis and serotonin system","name":"articletitle","label":"Article Title"},{"value":"Brain Research Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainresbull.2023.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}